142 related articles for article (PubMed ID: 32634263)
21. Specific high affinity interaction of Helicobacter pylori CagL with integrin α
Buß M; Tegtmeyer N; Schnieder J; Dong X; Li J; Springer TA; Backert S; Niemann HH
FEBS J; 2019 Oct; 286(20):3980-3997. PubMed ID: 31197920
[TBL] [Abstract][Full Text] [Related]
22. Phenothiazine-Biaryl-Containing Fluorescent RGD Peptides.
Ghabraie E; Kemker I; Tonali N; Ismail M; Dodero VI; Sewald N
Chemistry; 2020 Sep; 26(52):12036-12042. PubMed ID: 32297686
[TBL] [Abstract][Full Text] [Related]
23. Bifunctional ligands that target cells displaying the alpha v beta3 integrin.
Owen RM; Carlson CB; Xu J; Mowery P; Fasella E; Kiessling LL
Chembiochem; 2007 Jan; 8(1):68-82. PubMed ID: 17154219
[TBL] [Abstract][Full Text] [Related]
24. Biological Relevance of RGD-Integrin Subtype-Specific Ligands in Cancer.
Sani S; Messe M; Fuchs Q; Pierrevelcin M; Laquerriere P; Entz-Werle N; Reita D; Etienne-Selloum N; Bruban V; Choulier L; Martin S; Dontenwill M
Chembiochem; 2021 Apr; 22(7):1151-1160. PubMed ID: 33140906
[TBL] [Abstract][Full Text] [Related]
25. Modulation of αvβ₃- and α₅β₁-integrin-mediated adhesion by dehydro-β-amino acids containing peptidomimetics.
Tolomelli A; Baiula M; Belvisi L; Viola A; Gentilucci L; Troisi S; Dattoli SD; Spampinato S; Civera M; Juaristi E; Escudero M
Eur J Med Chem; 2013 Aug; 66():258-68. PubMed ID: 23811088
[TBL] [Abstract][Full Text] [Related]
26. Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and α(IIb)β3 integrin-rich intact cells by NMR and computational studies.
Guzzetti I; Civera M; Vasile F; Araldi EM; Belvisi L; Gennari C; Potenza D; Fanelli R; Piarulli U
Org Biomol Chem; 2013 Jun; 11(23):3886-93. PubMed ID: 23657523
[TBL] [Abstract][Full Text] [Related]
27. Cyclopropane pipecolic acids as templates for linear and cyclic peptidomimetics: application in the synthesis of an Arg-Gly-Asp (RGD)-containing peptide as an αvβ3 integrin ligand.
Sernissi L; Petrović M; Scarpi D; Guarna A; Trabocchi A; Bianchini F; Occhiato EG
Chemistry; 2014 Aug; 20(35):11187-203. PubMed ID: 25069617
[TBL] [Abstract][Full Text] [Related]
28. Determining the True Selectivity Profile of αv Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New Problem.
Rowedder JE; Ludbrook SB; Slack RJ
SLAS Discov; 2017 Sep; 22(8):962-973. PubMed ID: 28414923
[TBL] [Abstract][Full Text] [Related]
29. Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders.
Casiraghi G; Rassu G; Auzzas L; Burreddu P; Gaetani E; Battistini L; Zanardi F; Curti C; Nicastro G; Belvisi L; Motto I; Castorina M; Giannini G; Pisano C
J Med Chem; 2005 Dec; 48(24):7675-87. PubMed ID: 16302808
[TBL] [Abstract][Full Text] [Related]
30. Cyclic isoDGR peptidomimetics as low-nanomolar αvβ3 integrin ligands.
Mingozzi M; Dal Corso A; Marchini M; Guzzetti I; Civera M; Piarulli U; Arosio D; Belvisi L; Potenza D; Pignataro L; Gennari C
Chemistry; 2013 Mar; 19(11):3563-7. PubMed ID: 23424096
[No Abstract] [Full Text] [Related]
31. Bactrian camel (Camelus bactrianus) integrins alphavbeta3 and alphavbeta6 as FMDV receptors: molecular cloning, sequence analysis and comparison with other species.
Du J; Gao S; Chang H; Cong G; Lin T; Shao J; Liu Z; Liu X; Cai X
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):190-9. PubMed ID: 19443046
[TBL] [Abstract][Full Text] [Related]
32. Side chain effect in the modulation of α
Ferrazzano L; Corbisiero D; Potenza E; Baiula M; Dattoli SD; Spampinato S; Belvisi L; Civera M; Tolomelli A
Sci Rep; 2020 May; 10(1):7410. PubMed ID: 32366988
[TBL] [Abstract][Full Text] [Related]
33. Linear and Cyclic Depsipeptidomimetics with β-Lactam Cores: A Class of New α
Zabala-Uncilla N; Miranda JI; Laso A; Fernández X; Ganboa JI; Palomo C
Chembiochem; 2017 Apr; 18(7):654-665. PubMed ID: 28140512
[TBL] [Abstract][Full Text] [Related]
34. Pharmacophoric modifications lead to superpotent αvβ3 integrin ligands with suppressed α5β1 activity.
Neubauer S; Rechenmacher F; Brimioulle R; Di Leva FS; Bochen A; Sobahi TR; Schottelius M; Novellino E; Mas-Moruno C; Marinelli L; Kessler H
J Med Chem; 2014 Apr; 57(8):3410-7. PubMed ID: 24654918
[TBL] [Abstract][Full Text] [Related]
35. Insight to the binding mode of triazole RGD-peptidomimetics to integrin-rich cancer cells by NMR and molecular modeling.
Vasile F; Menchi G; Lenci E; Guarna A; Potenza D; Trabocchi A
Bioorg Med Chem; 2016 Mar; 24(5):989-94. PubMed ID: 26818999
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
[TBL] [Abstract][Full Text] [Related]
37. Development of isoxazoline-containing peptidomimetics as dual αvβ3 and α5β1 integrin ligands.
Tolomelli A; Gentilucci L; Mosconi E; Viola A; Dattoli SD; Baiula M; Spampinato S; Belvisi L; Civera M
ChemMedChem; 2011 Dec; 6(12):2264-72. PubMed ID: 21953988
[TBL] [Abstract][Full Text] [Related]
38. αvβ3- or α5β1-Integrin-Selective Peptidomimetics for Surface Coating.
Mas-Moruno C; Fraioli R; Rechenmacher F; Neubauer S; Kapp TG; Kessler H
Angew Chem Int Ed Engl; 2016 Jun; 55(25):7048-67. PubMed ID: 27258759
[TBL] [Abstract][Full Text] [Related]
39. The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human α
Borst AJ; James ZM; Zagotta WN; Ginsberg M; Rey FA; DiMaio F; Backovic M; Veesler D
Structure; 2017 Nov; 25(11):1732-1739.e5. PubMed ID: 29033288
[TBL] [Abstract][Full Text] [Related]
40. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
